Access Infusion Care

Access Infusion Care

Access Infusion Care was established in Gaylord, Michigan, as a single-family office anchored to the operating income of a specialty infusion-services business. The firm manages capital generated by the founders, who created and scaled a provider of in-office and ambulatory intravenous therapies — treatments that allow patients with chronic conditions to receive biologic drugs, hydration, and antibiotics outside hospital settings. The wealth engine is the operating company itself, not a liquidity event, which shapes the office's conservative, cash-flow-driven investment tempo. The firm deploys capital primarily into private-market opportunities, with a pronounced preference for direct investments in healthcare services and related real estate. Asset-class exposure spans private equity, real estate, and operating-company control stakes. The geographic footprint concentrates on the Midwest, with investments serving regional healthcare ecosystems in Michigan and neighboring states. The firm does not market itself to external limited partners and does not participate in blind-pool fund commitments as a passive investor; it pursues control or significant minority positions where the operators can apply their own clinical-operations expertise. The office maintains a lean structure, with investment decisions steered by the founding principals who remain active in the underlying infusion-care business. No additional office locations or adjacent philanthropic vehicles are publicly documented. The firm has not disclosed total assets under management, deployment figures, or specific portfolio-company holdings, consistent with a family office that does not solicit outside capital. The structural differentiator is the tight integration with an active operating business. Unlike financial-sponsor-backed family offices that invest from a pool of diversified liquid assets, Access Infusion Care's capital originates from ongoing healthcare operations. This creates an indefinite-time-horizon posture: the office can hold private investments through multiple cycles without facing redemption pressures, and it evaluates opportunities through the lens of clinical-operating experience rather than purely financial-return metrics.